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While murine-based systems to identify cancer-promoting agents (carcinogens) are established, models to 
identify compounds that promote aging (gerontogens) have not been described. For this purpose, we exploit-
ed the transcription of p16INK4a, which rises dynamically with aging and correlates with age-associated disease. 
Activation of p16INK4a was visualized in vivo using a murine strain that harbors a knockin of the luciferase 
gene into the Cdkn2a locus (p16LUC mice). We exposed p16LUC mice to candidate gerontogens, including arsenic, 
high-fat diet, UV light, and cigarette smoke and serially imaged animals to monitor senescence induction. We 
show that exposure to a high-fat diet did not accelerate p16INK4a expression, whereas arsenic modestly aug-
mented, and cigarette smoke and UV light potently augmented, activation of p16INK4a-mediated senescence. 
This work provides a toxicological platform to study mammalian aging and suggests agents that directly 
damage DNA promote molecular aging.
Introduction
Murine models have been critical to the identification of carcino-
gens. For example, commercially available models (i.e., BigBlue, 
MutaMouse, and the p53+/– strain; refs. 1–3) represent core tools 
in cancer toxicology. These reagents increase the efficiency and 
sensitivity of carcinogen identification, while reducing animal 
requirements and costs. In 1987, Martin proposed the concept 
of gerontogens (4): environmental agents that accelerate molecu-
lar aging, analogous to carcinogens promoting neoplasia. While 
murine models for carcinogen testing are advanced, in vivo tools 
for gerontogen testing do not exist.
Mammalian aging is complex, with distinct molecular processes 
contributing to age-related tissue dysfunction. While no single 
process underpins aging, several lines of evidence suggest senes-
cence activation is an important contributor. Markers of cellular 
senescence dramatically increase with aging in humans and mice, 
including expression of the p16INK4a tumor suppressor gene (5–8). 
Moreover, activation of p16INK4a and senescence has been linked 
to replicative hypofunction in neural stem cells (9), hematopoi-
etic progenitors (10), lymphocytes (11, 12), and pancreatic β cells 
(13). Altered regulation of the senescence-promoting CDKN2a/b 
locus, which encodes p16INK4a, p15INK4b, and ARF, has been linked 
to aging phenotypes, including atherosclerotic disease, type II dia-
betes, glaucoma, and several malignancies (14). Finally, pharma-
cologic and genetic approaches to manipulating the number of 
senescent cells in vivo can ameliorate age-associated phenotypes 
such as sarcopenia, kyphosis, and hyporeplication of T lympho-
cytes and pancreatic β cells (15–17). Here, we sought to determine 
whether in vivo activation of p16INK4a, measured using the recently 
described p16LUC reporter allele (18), could effectively assess the 
gerontogenic effects of environmental agents.
Results and Discussion
The p16LUC allele features firefly luciferase knocked in to exon 1α 
of the murine Cdkn2a locus (18), with expression under the control 
of the endogenous p16INK4a promoter and distant cis-regulatory 
elements (19, 20). Importantly, p16INK4a expression is negligible in 
healthy cells from young mice, but increases more than 300-fold 
on a per-cell basis with age-promoting stresses (7, 18). The large, 
dynamic range of p16INK4a expression makes p16LUC a valuable tool 
for in vivo imaging of senescence induction. To assess the effect of 
candidate gerontogens — high-fat diet (HFD), UV light, arsenic, 
and cigarette smoke (CS) — on senescence, we performed serial 
analysis of p16LUC cohorts.
Prior studies on the effects of obesity and HFD on p16INK4a 
expression in vivo have yielded inconsistent results. HFD has 
been reported to increase senescence and/or p16INK4a expression 
in vascular cells (21, 22), whereas p16INK4a mRNA expression in 
peripheral blood T lymphocytes (PBTLs) does not correlate with 
body mass index, a marker of obesity, in humans (8). To examine 
the effects of HFD on whole-body senescence, littermate p16LUC 
mice were placed on a 42%-fat HFD or 4%-fat normal diet (ND) for 
18 months starting at 8–10 weeks of age. HFD feeding produced 
a clear pharmacodynamic effect, causing significant weight gain 
and hepatic steatosis, although no differences in overall survival 
were noted (Supplemental Figure 1, A–C; supplemental mate-
rial available online with this article; doi:10.1172/JCI70960DS1). 
Consistent with prior reports (7, 18), we observed an exponen-
tial increase in p16INK4a expression with aging; however, the rate 
of increase, as assessed by total-body luciferase imaging (TBLI), 
was not different between cohorts (Figure 1, A and B). Due to the 
wide range of weight gain among HFD-fed mice, we analyzed the 
relationship between weight and luciferase intensity at 52 weeks 
and observed no correlation (Supplemental Figure 1D). Corre-
Conflict of interest: Norman E. Sharpless has received financial support from 
MolecularMD and has an equity stake in G1 Therapeutics.
Note regarding evaluation of this manuscript: Manuscripts authored by scientists 
associated with Duke University, The University of North Carolina at Chapel Hill, 
Duke-NUS, and the Sanford-Burnham Medical Research Institute are handled not 
by members of the editorial board but rather by the science editors, who consult with 
selected external editors and reviewers.
Citation for this article: J Clin Invest. 2014;124(1):169–173. doi:10.1172/JCI70960.
brief report
170 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 1   January 2014
spondingly, expression of p16INK4a mRNA was not altered in liver 
and spleen harvested from 18-month-old mice fed HFD versus ND 
(Supplemental Figure 1E). These data suggested that HFD does 
not accelerate p16INK4a expression in vivo, at least within the sensi-
tivity of luciferase detection.
Arsenic is an environmental toxicant linked to human aging-
associated phenotypes (i.e., several cancers, type II diabetes, and 
atherosclerosis; ref. 23). While not a direct clastogen, arsenic may 
indirectly affect DNA damage and repair (24–26). We examined the 
effect of chronic arsenic exposure on p16INK4a expression in vivo by 
administering 0 or 50 ppm arsenic to littermate p16LUC mice in the 
drinking water for 12 months starting at 8–10 weeks of age. After 
48 weeks of exposure, arsenic-treated mice exhibited significant 
hepatic accumulation (Supplemental Figure 2A). Consistent with 
known effects of arsenic (27), treated mice showed small, structur-
ally deranged pancreatic islets with an extreme decrease in total islet 
mass (Supplemental Figure 2, B and C). Overall survival rates were 
not different between cohorts (Supplemental Figure 2D). A mod-
est but significant increase in p16INK4a expression was observed by 
24 weeks of exposure using TBLI (P = 0.023; Figure 1, C and D). 
Additionally, expression of p16INK4a mRNA was higher in spleen, but 
not liver, of 1-year-old mice administered 50 versus 0 ppm (Supple-
mental Figure 2E). These data suggest that chronic arsenic exposure 
modestly accelerates the accumulation of p16INK4a-expressing cells.
CS promotes DNA damage (28, 29) and age-related diseases such as 
emphysema, atherosclerosis, and several cancers (30, 31). Chronic CS 
exposure in humans is associated with increased p16INK4a expression 
in PBTLs (8, 32). To determine the effects of moderate CS exposure 
on cellular senescence in vivo, littermate p16LUC mice were exposed 
to CS or ambient air (AA) for 1 hour per day, 5 days per week for 
6 months starting at 10–12 weeks of age. After 6 months of exposure, 
mice were further observed without CS up to 1 year of age. At the end 
of the study, histological analysis of the sinus cavity of CS-exposed 
mice showed particulate deposits along the epithelial layer of the 
nasal papilla, whereas no differences were noted in lung architecture 
between CS and AA cohorts at this tobacco dose (Figure 2A), which 
Figure 1
HFD does not increase p16INK4a expression, while arsenic moderately increases p16INK4a expression. p16LUC mice were (A and B) fed ND or HFD 
or (C and D) exposed to 0 or 50 ppm arsenic. (A and C) Luciferase intensity, normalized to mean luciferase levels of the entire cohort at day 0 and 
graphed as a function of time. Exposure duration is shown by the orange bar on the x axis. Error bars indicate SEM. P values were determined 
by linear regression analysis. (B and D) Representative TBLI of experiments in A and C, respectively.
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was also not associated with accelerated mortality (Supplemental 
Figure 3A). A significant increase in p16INK4a induction between the 
CS and AA cohorts, as measured by TBLI, was readily noted with-
in weeks of CS exposure and persisted after CS was discontinued 
(Figure 2B). Consistent with histologic examinations of the nasal 
cavities and lungs (Figure 2A), luciferase induction was noted in the 
head and neck region of mice, but not the thoracic and abdominal 
regions (Figure 2C). Correspondingly, p16INK4a mRNA levels in the 
liver, lung, axillary lymph nodes, and spleen were similar in CS- and 
AA-exposed mice (Supplemental Figure 3B). These data suggest that 
low-dose CS exposure accelerates accumulation of senescent cells in 
tissues that receive the highest exposure (i.e., nasal epithelium).
Chronic UVB exposure causes photoaging and skin cancer (33, 34). 
To directly assess whether chronic UVB induces senescence in vivo, 
the dorsal surface of p16LUC mice was exposed to 350 J/m2 UVB light 
3 times a week for 6 months starting at 10–12 weeks of age. Litter-
mate control mice were contemporaneously aged in the absence 
of UVB. After 6 months of exposure, mice were observed without 
further UVB exposure until 1 year of age. After 6 months of expo-
sure, UV-exposed mice showed hyperkeratosis and metaplasia and 
inflammatory infiltration of the dermis and hypodermis compared 
with the nonexposed cohort (Figure 3A). The DNA damage marker 
phospho-H2AX was substantially increased in the epithelium of UV-
exposed mice (Figure 3A and Supplemental Figure 4A), suggesting 
a persistent DNA damage response. Additionally, UV-exposed mice 
developed skin neoplasms within 5 months of exposure, which accel-
erated mortality (Figure 3, B and C). Luciferase expression was higher 
in p16LUC animals treated with UV than in unexposed controls prior 
to development of visible neoplasms, and TBLI was almost 8 times 
greater in UV-treated animals after 32 weeks of exposure (Figure 3D). 
In accord with the TBLI results (Figure 3E), p16INK4a mRNA levels 
from abdominal and dorsal skin from both cohorts confirmed the 
site-specific induction of p16INK4a expression (Figure 3F). Addition-
ally, the UV-exposed dorsal skin exhibited higher expression than 
unexposed abdominal skin from the same mouse (Figure 3F).
To strengthen the association of p16INK4a induction with senescence, 
additional markers were analyzed in UV-exposed and unexposed skin, 
including mRNA of the senescence-associated (SA) cytokines Cxcl1 
and Il6 and SA-β-galactosidase (SA-β-gal) staining. Cxcl1 and Il6 
expression increased in UV-exposed versus nonexposed mice. Addi-
tionally, increased expression only occurred in skin directly exposed to 
UV light (back) and not in unexposed skin (abdomen) from the same 
animals (Figure 3, G and H). We observed a similar pattern of SA-β-gal 
staining (Supplemental Figure 4B). These data suggest that chronic 
DNA damage from UV light accelerates senescent cell accumulation.
Here, we demonstrated that p16LUC mice can detect the senes-
cence-promoting effects of environmental exposures. Direct DNA-
damaging agents (CS and UV light) appeared potently geronto-
genic, and arsenic exposure produced a lesser, but significant, 
effect. We also identified anatomic gerontogenic effects of these 
Figure 2
CS increases p16INK4a expression. p16LUC mice were exposed to CS or AA. (A) Upper sinus cavity (top), airway bronchioles (middle; airway epi-
thelium peg cells highlighted), and alveolar sacs (bottom) after 54 weeks. Arrows indicate areas of particulate deposit along the epithelial layer. 
Original magnification, ×40, ×280 (insets). (B) Luciferase intensity, normalized to mean luciferase levels of the entire cohort at day 0 and graphed 
as a function of time. Exposure duration is shown by the orange bar on the x axis. Error bars indicate SEM. P value was determined by linear 
regression analysis. (C) Representative TBLI of experiments in B.
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Figure 3
UVB increases p16INK4a expression. p16LUC mice were exposed to 0 J/m2 (n = 13) or 350 J/m2 (n = 11) UVB light. (A) Representative histopatholog-
ical images of skin stained with H&E or phospho-H2AX. Original magnification, ×20 (top), ×40 (middle and bottom), ×200 (top, insets), ×120 (mid-
dle and bottom, insets). (B) Representative dorsal images. (C) Kaplan-Meier survival curves. Exposure duration is shown by the orange bar on the 
x axis. P value was determined by Gehan-Breslow-Wilcoxon test. (D) Luciferase intensity, normalized to mean levels of the entire cohort at day 0 
and graphed as a function of time. Exposure duration is shown by the orange bar on the x axis. Inset highlights initial 20 weeks of exposure. Error 
bars denote SEM. P value was determined by linear regression analysis. (E) Representative TBLI of experiments in D. (F–H) Quantitative real-
time PCR of p16INK4a (F), Cxcl1 (G), and Il6 (H) expression in back and abdominal skin at sacrifice. Error bars denote SEM. *P < 0.05, **P < 0.01, 
***P < 0.005, Student’s t test.
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Hairless SKH1-E p16LUC/+ mice were used for all experiments (18). Geno-
typing was performed as previously described (18). For histologic analysis, 
tissues were fixed with 10% formalin overnight, then transferred to 70% etha-
nol for paraffin blocking and staining. Quantitative TaqMan RT-PCR strate-
gies for detection of p16INK4a were performed as previously described (7, 13).
Statistics. Statistical significance was determined using 2-tailed Student’s 
t test or linear regression analysis for all comparisons, except survival analy-
sis (Gehan-Breslow-Wilcoxon test). A P value less than 0.05 was considered 
statistically significant.
Study approval. Experiments were performed under protocols approved 
by the University of North Carolina IACUC. 
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agents, including a stronger effect of passively inhaled CS on nasal 
epithelia than lung parenchyma (Figure 2C) and effects of UVB on 
exposed rather than unexposed skin (Figure 3, E and F).
This system has some important limitations. First, although lucif-
erase imaging is considerably more sensitive than optical methods, 
the p16LUC allele may be less useful for detecting senescence in deeper 
organs or in rare cellular subtypes. Therefore, while we observed no 
effect of HFD on TBLI, it is possible that HFD activates senescence 
in important cellular compartments (e.g., pancreatic β cells, ref. 35; 
and vascular cells, refs. 21, 22), but not to a level detectable using 
this system. Similarly, while we showed that gerontogen-induced 
p16INK4a expression occurred spatially near senescent cells, we have 
not explicitly demonstrated that p16INK4a-expressing cells are in all 
cases senescent. Finally, the p16LUC allele cannot be used to identify 
p16INK4a-independent gerontogens or aging processes.
In summary, we demonstrated using modest-sized cohorts of 
serially analyzed animals that the p16LUC allele reported in vivo acti-
vation of senescence markers and uncovered gerontogenic effects 
of environmental toxicants. This resource can supplement other 
rodent platforms used for toxicological assessments; specifically, 
it represents an in vivo system with which to assess a compound’s 
age-promoting activity. We believe this resource will provide an 
important tool for understanding the relationship between envi-
ronmental exposures and molecular aging.
Methods
Further information can be found in Supplemental Methods.
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